1. Montelukast, cysteinyl leukotriene receptor 1 antagonist, inhibits cardiac fibrosis by activating APJ;Y Wu;Eur. J. Pharmacol,2022
2. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial;T F Reiss;Arch. Intern. Med,1998
3. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period;J Van Adelsberg;Allergy,2003
4. Effect of azelastine hydrochloride combined with montelukast sodium in the treatment of patients with allergic rhinitis;Q Zheng;Am. J. Transl. Res,2021
5. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction, New Engl;J A Leff;J. Med,1998